Combination therapy with alisertib enhances the anti-tumor immunity induced by a liver cancer vaccine

Summary: Alisertib is a potent aurora A kinase inhibitor in clinical trials for cancer treatment, but its efficacy on cancer vaccines remains unclear. Here, we developed a DNA vaccine targeting glypican-3 (pGPC3) and evaluated its efficacy with alisertib in hepatocellular carcinoma (HCC) models. The...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Fang Xue, Jing Liu, Jinyan Wu, Xueer Li, Ningning Zhu, Shuting Tang, Mengli Zhang, Huan Duan, Rui Wang, Jing Zhang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2025-04-01
Serie:	iScience
Soggetti:	Natural sciences Biological sciences Immunology Systems biology Cancer systems biology
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2589004225003803
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!